Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Myriad Genetics stock

Learn how to easily invest in Myriad Genetics stock.

Myriad Genetics Inc is a diagnostics & research business based in the US. Myriad Genetics shares (MYGN) are listed on the NASDAQ and all prices are listed in US Dollars. Myriad Genetics employs 2,400 staff and has a trailing 12-month revenue of around $672.3 million.

How to buy shares in Myriad Genetics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MYGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Myriad Genetics stock price (NASDAQ: MYGN)

Use our graph to track the performance of MYGN stocks over time.

Myriad Genetics shares at a glance

Information last updated 2022-09-27.
Latest market close$19.08
52-week range$16.02 - $33.18
50-day moving average $23.88
200-day moving average $23.44
Wall St. target price$25.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.11

Buy Myriad Genetics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Myriad Genetics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Myriad Genetics price performance over time

Historical closes compared with the close of $19.08 from 2022-09-30

1 week (2022-09-22) -0.31%
1 month (2022-08-28) N/A
3 months (2022-06-28) 3.64%
6 months (2022-04-01) -26.28%
1 year (2021-10-01) -40.17%
2 years (2020-10-01) 44.87%
3 years (2019-10-01) 28.29
5 years (2017-09-29) 36.18

Is Myriad Genetics stock undervalued or overvalued?

Valuing Myriad Genetics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Myriad Genetics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Myriad Genetics's PEG ratio

Myriad Genetics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.2877. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Myriad Genetics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Myriad Genetics financials

Revenue TTM $672.3 million
Gross profit TTM $493 million
Return on assets TTM -4.56%
Return on equity TTM -1.9%
Profit margin -2.62%
Book value $11.75
Market capitalisation $1.5 billion

TTM: trailing 12 months

Myriad Genetics share dividends

We're not expecting Myriad Genetics to pay a dividend over the next 12 months.

Have Myriad Genetics's shares ever split?

Myriad Genetics's shares were split on a 2:1 basis on 26 March 2009. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Myriad Genetics shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Myriad Genetics shares which in turn could have impacted Myriad Genetics's share price.

Myriad Genetics share price volatility

Over the last 12 months, Myriad Genetics's shares have ranged in value from as little as $16.02 up to $33.18. A popular way to gauge a stock's volatility is its "beta".

MYGN.US volatility(beta: 1.75)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Myriad Genetics's is 1.7503. This would suggest that Myriad Genetics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Myriad Genetics overview

Myriad Genetics, Inc. , a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, a RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, a RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. In addition, it provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, ADHD, and other mental health conditions. Myriad Genetics, Inc.

Frequently asked questions

What percentage of Myriad Genetics is owned by insiders or institutions?
Currently 2% of Myriad Genetics shares are held by insiders and 101.069% by institutions.
How many people work for Myriad Genetics?
Latest data suggests 2,400 work at Myriad Genetics.
When does the fiscal year end for Myriad Genetics?
Myriad Genetics's fiscal year ends in June.
Where is Myriad Genetics based?
Myriad Genetics's address is: 320 Wakara Way, Salt Lake City, UT, United States, 84108
What is Myriad Genetics's ISIN number?
Myriad Genetics's international securities identification number is: US62855J1043
What is Myriad Genetics's CUSIP number?
Myriad Genetics's Committee on Uniform Securities Identification Procedures number is: 62855J104

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site